PE20070723A1 - Imidazopirazinas como inhibidores de quinasas dependientes de ciclina - Google Patents
Imidazopirazinas como inhibidores de quinasas dependientes de ciclinaInfo
- Publication number
- PE20070723A1 PE20070723A1 PE2006001397A PE2006001397A PE20070723A1 PE 20070723 A1 PE20070723 A1 PE 20070723A1 PE 2006001397 A PE2006001397 A PE 2006001397A PE 2006001397 A PE2006001397 A PE 2006001397A PE 20070723 A1 PE20070723 A1 PE 20070723A1
- Authority
- PE
- Peru
- Prior art keywords
- cycline
- inhibitors
- dependent kinases
- imidazopyrazines
- influencies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
REFERIDA A UN COMPUESTO DERIVADO DE IMIDAZOPIRAZINA DE FORMULAS (a), (b), (c), (d), ENTRE OTRAS O UNA SAL, SOLVATO O ESTER DE LOS MISMOS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE PROTEINA QUINASA TALES COMO QUINASAS DEPENDIENTES DE CICLINA, PROTEINA QUINASA ACTIVADA POR MITOGENO, GLUCOGENO SINTASA QUINASA 3 Y SIMILARES, Y SON UTILES EN EL TRATAMIENTO DEL CANCER, INFLAMACION, ARTRITIS, ENFERMEDADES VIRALES, ENFERMEDADES NEURODEGENERATIVAS, CARIOVASCULARES Y FUNGICAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/272,392 US7576085B2 (en) | 2002-09-23 | 2005-11-10 | Imidazopyrazines as cyclin dependent kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20070723A1 true PE20070723A1 (es) | 2007-08-10 |
Family
ID=38002043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006001397A PE20070723A1 (es) | 2005-11-10 | 2006-11-08 | Imidazopirazinas como inhibidores de quinasas dependientes de ciclina |
Country Status (9)
Country | Link |
---|---|
US (1) | US7576085B2 (es) |
EP (1) | EP1945643A2 (es) |
JP (1) | JP5109109B2 (es) |
CN (1) | CN101331135A (es) |
AR (1) | AR058780A1 (es) |
CA (1) | CA2627965A1 (es) |
PE (1) | PE20070723A1 (es) |
TW (1) | TW200804387A (es) |
WO (1) | WO2007058873A2 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7576085B2 (en) * | 2002-09-23 | 2009-08-18 | Schering Corporation | Imidazopyrazines as cyclin dependent kinase inhibitors |
JP2008542219A (ja) * | 2005-05-25 | 2008-11-27 | インゲニウム ファーマシューティカルズ ジーエムビーエイチ | 疼痛処置法 |
TW200800213A (en) * | 2005-09-02 | 2008-01-01 | Abbott Lab | Novel imidazo based heterocycles |
AU2006315718B2 (en) * | 2005-11-10 | 2012-10-04 | Merck Sharp & Dohme Corp. | Imidazopyrazines as protein kinase inhibitors |
EP1945216A1 (en) | 2005-11-10 | 2008-07-23 | Schering Corporation | Methods for inhibiting protein kinases |
MX2008015747A (es) * | 2006-06-06 | 2008-12-19 | Schering Corp | Imidazopirazinas como inhibidores de la proteina quinasa. |
JP2010510222A (ja) * | 2006-11-17 | 2010-04-02 | シェーリング コーポレイション | 増殖性障害に対する併用療法 |
EP2086540B8 (en) * | 2006-12-01 | 2011-03-02 | Galapagos N.V. | Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
US20080249305A1 (en) * | 2007-03-27 | 2008-10-09 | Calderwood David J | Novel imidazole based heterocycles |
US8507498B2 (en) | 2007-04-24 | 2013-08-13 | Ingenium Pharmaceuticals Gmbh | 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases |
WO2008138842A1 (en) * | 2007-05-10 | 2008-11-20 | Galapagos N.V. | Imidazopyrazines and triazolopyrazine for the treatment of joint degenerative and inflammatory diseases |
US8133895B2 (en) * | 2007-05-10 | 2012-03-13 | Janssen Pharmaceutica N.V. | Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
MX2009013729A (es) * | 2007-06-14 | 2010-01-25 | Schering Corp | Imidazopirazinas como inhibidores de proteina quinasa. |
DE102007032349A1 (de) | 2007-07-11 | 2009-01-15 | Bayer Healthcare Ag | Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung |
US20100249030A1 (en) * | 2007-07-31 | 2010-09-30 | Schering Corporation | Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
GB0716292D0 (en) * | 2007-08-21 | 2007-09-26 | Biofocus Dpi Ltd | Imidazopyrazine compounds |
DE102008023801A1 (de) | 2008-05-15 | 2009-11-19 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine |
JP2012521354A (ja) * | 2009-03-20 | 2012-09-13 | アムジエン・インコーポレーテツド | Pi3キナーゼの阻害薬 |
TW201107329A (en) * | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
US8993535B2 (en) | 2009-09-04 | 2015-03-31 | Merck Sharp & Dohme Corp. | Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
WO2011051342A1 (en) | 2009-10-30 | 2011-05-05 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
AR080754A1 (es) * | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
ES2551407T3 (es) | 2010-03-18 | 2015-11-18 | Bayer Intellectual Property Gmbh | Imidazopirazinas |
ES2555261T3 (es) | 2010-06-01 | 2015-12-30 | Bayer Intellectual Property Gmbh | Imidazopirazinas sustituidas |
US20140135319A1 (en) * | 2010-12-17 | 2014-05-15 | Bayer Intellectual Property Gmbh | 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
EA027418B1 (ru) | 2011-06-27 | 2017-07-31 | Янссен Фармацевтика Нв | ПРОИЗВОДНЫЕ 1-АРИЛ-4-МЕТИЛ[1,2,4]ТРИАЗОЛО[4,3-a]ХИНОКСАЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБЫ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ ИХ, ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ |
CN102659785B (zh) * | 2012-05-11 | 2014-04-30 | 山东大学 | 一种2-氨基-6-氨甲基嘌呤类化合物及其制备方法和应用 |
WO2014001314A1 (en) | 2012-06-26 | 2014-01-03 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
BR112015000459B1 (pt) | 2012-07-09 | 2022-02-08 | Janssen Pharmaceutica N.V. | Inibidores da enzima fosfodiesterase 10, seu uso, composição farmacêutica que os compreende, seus processo de preparação e produto |
KR20180083902A (ko) | 2015-11-18 | 2018-07-23 | 젠자임 코포레이션 | 다낭성 신장병의 바이오마커 및 그의 용도 |
WO2021249417A1 (zh) * | 2020-06-09 | 2021-12-16 | 赛诺哈勃药业(成都)有限公司 | 杂环化合物及其衍生物 |
WO2022061155A1 (en) * | 2020-09-17 | 2022-03-24 | The Translational Genomics Research Institute | Imidazopyridazine and imidazopyrazine compounds as inhibitors of cdk7 |
CN116715668A (zh) * | 2022-03-07 | 2023-09-08 | 上海凌达生物医药有限公司 | 一类含氮杂环类细胞周期抑制剂化合物、制备方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026310A1 (en) * | 2002-09-23 | 2004-04-01 | Schering Corporation | Novel imidazopyrazines as cyclin dependent kinase inhibitors |
US7576085B2 (en) * | 2002-09-23 | 2009-08-18 | Schering Corporation | Imidazopyrazines as cyclin dependent kinase inhibitors |
DE60317353T2 (de) * | 2002-09-23 | 2008-08-28 | Schering Corp. | Imidazopyrazine als cdk-inhibitoren |
MXPA05009885A (es) * | 2003-03-14 | 2005-12-05 | Astrazeneca Ab | Nuevas triazolonas fusionadas y los usos de las mismas. |
GB0405055D0 (en) * | 2004-03-05 | 2004-04-07 | Eisai London Res Lab Ltd | JNK inhibitors |
AU2006315718B2 (en) * | 2005-11-10 | 2012-10-04 | Merck Sharp & Dohme Corp. | Imidazopyrazines as protein kinase inhibitors |
-
2005
- 2005-11-10 US US11/272,392 patent/US7576085B2/en not_active Expired - Fee Related
-
2006
- 2006-11-08 WO PCT/US2006/043592 patent/WO2007058873A2/en active Application Filing
- 2006-11-08 CN CNA2006800471130A patent/CN101331135A/zh active Pending
- 2006-11-08 EP EP06837219A patent/EP1945643A2/en not_active Withdrawn
- 2006-11-08 AR ARP060104895A patent/AR058780A1/es not_active Application Discontinuation
- 2006-11-08 JP JP2008540178A patent/JP5109109B2/ja not_active Expired - Fee Related
- 2006-11-08 PE PE2006001397A patent/PE20070723A1/es not_active Application Discontinuation
- 2006-11-08 CA CA002627965A patent/CA2627965A1/en not_active Abandoned
- 2006-11-09 TW TW095141554A patent/TW200804387A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP5109109B2 (ja) | 2012-12-26 |
AR058780A1 (es) | 2008-02-20 |
CN101331135A (zh) | 2008-12-24 |
CA2627965A1 (en) | 2007-05-24 |
US20060106023A1 (en) | 2006-05-18 |
WO2007058873A3 (en) | 2007-07-19 |
JP2009515883A (ja) | 2009-04-16 |
US7576085B2 (en) | 2009-08-18 |
EP1945643A2 (en) | 2008-07-23 |
TW200804387A (en) | 2008-01-16 |
WO2007058873A2 (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20070723A1 (es) | Imidazopirazinas como inhibidores de quinasas dependientes de ciclina | |
ECSP088906A (es) | PIRAZOLO 1,5-a PIRIMIDINAS | |
ECSP088440A (es) | Imidazopirazinas como inhibidores de proteinquinasa | |
ECSP077324A (es) | Amidas bicíclicas como inhibidores de cinasa | |
GT200600517A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
MX2009005011A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
ECSP088345A (es) | Nuevas pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina | |
CL2008001745A1 (es) | Compuestos derivados de imidazo[1,2-a]pirazina; composición farmacéutica; y uso de los compuestos como inhibidores de la proteína quinasa en el tratamiento del cáncer. | |
ECSP088350A (es) | Pirazolopirimidinas como inhibidores de protein quinasas | |
EA200901138A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
CL2007000806A1 (es) | Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer. | |
ECSP109934A (es) | Compuesto - 946 | |
CL2008001103A1 (es) | Compuestos derivados de [1,2,3]triazolo[4,5-b]piridin-corboxamidas y [1,2,3]triazolo[4,5-d]pirimidin-carboxamidas, inhibidores de megl y faah; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento de dolores agudos o cronicos, vertigos, vomitos, nauseas, sindrome metabolico, dislipidemia, entre otros. | |
CL2007002593A1 (es) | Compuestos derivados de 4-heteroaril-piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como rechazo de organos transplantados, sindromes autoinmunes y cancer. | |
CL2008001540A1 (es) | Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer. | |
CL2007003774A1 (es) | Compuestos derivados de quinazolina sustituidos, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, aterosclerosis y artritis. | |
EA200901133A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
CL2008003023A1 (es) | (s)-4-amino-n-(1-(4-clorofenil)-3-hidroxipropil)-1-(7h-pirrolo[2,3-d]pirimidin-4-il)piperidina-4-carboxamida, inhibidor de la proteina quinasa b; procedimiento de preparacion; compuestos intermediarios; composicion farmacéutica que comprende dicho compuesto; y uso para el tratamiento del cancer. | |
CL2008001373A1 (es) | Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer. | |
CL2008001633A1 (es) | Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer. | |
AR063097A1 (es) | Pirazolopirimidinas[1,5-a] inhibidoras de quinasas dependientes de ciclina(cdk), composiciones farmaceuticas que las contienen y usos en el tratamiento de enfermedades proliferativas | |
CL2008001104A1 (es) | Compuestos derivados de [1,2,3]triazolo[4,5-b]piridin-carboxamidas y [1,2,3]triazolo[4,5-d]pirimidin-carboxamidas, inhibidores de mgl y faah; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento de delolores agudos o cronicos, vertigos, vomitos, nauseas, sindrome metaloico, dispipidemia, entre otros. | |
GT200900201A (es) | Formulaciones para el tratamiento del cáncer. | |
DE602006007037D1 (de) | Pyrrolotriazin-kinasehemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |